Given that ETV6::ABL1 has been predominantly reported in both MPN and AML, we retrospectively assessed and confirmed the presence of ETV6::ABL1 during the initial MPN phase using RT-PCR. This evidence concerns the gene ETV6 and myeloproliferative disorder.